Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
438.10Prev. Close
438.10Volume
3,67,408Total traded value
16.00 CrUpper Circuit
522.50Lower Circuit
348.40Fundamentals
| Market Cap | ₹2,680Cr |
| ROE | -5.22% |
| P/E Ratio(TTM) | 240.44 |
| EPS(TTM) | 1.82 |
| P/B Ratio | 3.30 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.32 |
| Book Value | 132.75 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Panacea Biotec
Panacea Biotec is a leading biotechnology company that specialises in making innovative vaccines and high-end generic medicines to address global health challenges. The company operates with the core mission of 'Innovation in Support of Life,' focusing on creating ground-breaking and affordable healthcare solutions. Demonstrating its massive scale, the company has supplied over 10 billion doses of its polio vaccine across India and other developing countries.;
| Parent Organisation | Panacea Biotec |
| Managing Director | Dr. Rajesh Jain |
| NSE Symbol | PANACEABIO |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 71.84 | ||
| Anthem Biosciences | NA (0.00%) | 96.11 | ||
| Onesource Specialty Pharma | NA (0.00%) | 317.19 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 24.88 |